Best Ulcerative Colitis Treatment Doctors in India
Dr. (Col) Avnish Seth
Whatsapp Us
Dr. Sanjiv Saigal
Dr. Charles Panackel
Dr. Mallikarjun Sakpal
Dr. Narendra Singh Choudhary
Dr. Geeta Malkan Billa
What Patients with Ulcerative Colitis Worry About Most
Ulcerative colitis is a long-term inflammatory condition that affects the colon and rectum. Patients worry about blood in the stool, urgency, frequent toilet visits, and the long-term risk of colon cancer. Many are young adults already on aminosalicylates and steroids, with disease that comes and goes. The honest position is that ulcerative colitis is a lifelong condition, but modern targeted therapy has changed the outlook. Deep remission is realistic for most patients, and colectomy with ileal pouch-anal anastomosis is a good option when medical therapy fails or the cancer risk becomes unacceptable.
How Ulcerative Colitis Is Diagnosed
Diagnosis combines symptoms (bloody diarrhoea, urgency, tenesmus, abdominal cramps), ileocolonoscopy, and histology. Colonoscopy maps the extent (proctitis, left-sided, extensive) and grades severity. Biopsies confirm chronic inflammation and rule out infection. Faecal calprotectin tracks inflammation between scopes. Blood tests include haemoglobin, ferritin, C-reactive protein, albumin, liver function (to screen for primary sclerosing cholangitis), and vitamin D. Stool cultures including Clostridioides difficile are mandatory at diagnosis and at flare. Flexible sigmoidoscopy is used for severe acute colitis where full colonoscopy is unsafe.
Treatment Options for Ulcerative Colitis in India
Treatment is matched to severity, extent, and prior response. Mesalazine, oral and topical, is the backbone of mild-to-moderate disease and maintenance. Corticosteroids (prednisolone, budesonide) are used for short courses to induce remission. Thiopurines (azathioprine) are steroid-sparing. Biologic agents are now central in moderate-to-severe disease: anti-tumour necrosis factor drugs (infliximab, adalimumab, golimumab), anti-integrin (vedolizumab), and anti-interleukin therapy (ustekinumab, mirikizumab). Janus kinase inhibitors (tofacitinib, upadacitinib) and the sphingosine-1-phosphate receptor modulator ozanimod are oral options. Surgery (subtotal colectomy in emergency, completion proctectomy with ileal pouch-anal anastomosis later) cures the bowel disease in around twenty percent of patients over time. Fortis Memorial Research Institute, Medanta, Apollo Hospitals, Asian Institute of Gastroenterology, Sir Ganga Ram Hospital, and All India Institute of Medical Sciences run dedicated ulcerative colitis clinics.
Recovery, Success Rates, and Follow-Up
Modern biologic therapy and Janus kinase inhibitors induce remission in around half to two-thirds of moderate-to-severe ulcerative colitis, with most maintaining response at one year. Severe acute colitis admitted to hospital responds to intravenous steroids in around two-thirds, with rescue infliximab or ciclosporin for the rest. Ileal pouch-anal anastomosis after colectomy gives a continent reservoir with around five to six bowel motions per day and good long-term function in selected patients. Surveillance colonoscopy from eight years after diagnosis (sooner if primary sclerosing cholangitis coexists) reduces colon cancer mortality.
How to Choose the Right Gastroenterologist for Ulcerative Colitis
Ask the centre about the full range of biologic agents, Janus kinase inhibitors, and sphingosine-1-phosphate receptor modulators offered, access to therapeutic drug monitoring, and the link with a colorectal surgeon experienced in laparoscopic and robotic ileal pouch-anal anastomosis. Ask about the multidisciplinary inflammatory bowel disease clinic, dietitian and psychology support, and the personalised plan for pregnancy, vaccination, and surveillance colonoscopy.
International Patient Support
International patients receive a single coordinator who arranges colonoscopy, biologic therapy, surgery if needed, and surveillance. The Cancer Rounds team supports medical visa invitation letters, accommodation, airport transfers, and multilingual support in eleven plus languages. Patients arrive from Nigeria, Bangladesh, Kenya, Ethiopia, Iraq, Oman, and the United Arab Emirates for ulcerative colitis care. A written long-term plan and cost estimate are shared before travel.
Frequently Asked Questions
Will I need my colon removed?
Around twenty percent of patients with ulcerative colitis need colectomy over a lifetime, usually for medical therapy failure, severe acute colitis, dysplasia, or cancer. Many never need surgery thanks to modern targeted therapy.
What is an ileal pouch-anal anastomosis?
Ileal pouch-anal anastomosis is a surgery where the end of the small bowel is fashioned into a J-shaped pouch and joined to the anus after colon and rectum removal. It avoids a permanent stoma and preserves continence in selected patients.
Does ulcerative colitis increase cancer risk?
Long-standing extensive colitis increases colon cancer risk, with bigger risk in those with primary sclerosing cholangitis and family history. Surveillance colonoscopy from eight years after diagnosis, with chromoendoscopy or high-definition imaging, makes this risk well managed.
Can I have children safely?
Fertility is largely normal in ulcerative colitis in remission. Most medications are continued through pregnancy under specialist guidance. Disease control before and during pregnancy is the most important factor for a healthy outcome.
How is severe acute colitis treated?
Severe acute colitis is a medical emergency. Treatment is hospital admission, intravenous steroids, prophylactic anticoagulation, and rescue therapy with infliximab or ciclosporin if no response by day three. Colectomy is offered if rescue therapy fails.
Does smoking affect ulcerative colitis?
Smoking has a paradoxical mild protective effect in ulcerative colitis, the opposite of Crohn disease. Even so, smoking causes major harm to heart, lung, and cancer risk. Patients should not start or restart smoking for ulcerative colitis.
